These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8612380

  • 1. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
    Mrozikiewicz PM, Cascorbi I, Brockmöller J, Roots I.
    Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
    [Abstract] [Full Text] [Related]

  • 2. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.
    Doll MA, Fretland AJ, Deitz AC, Hein DW.
    Anal Biochem; 1995 Nov 01; 231(2):413-20. PubMed ID: 8594994
    [Abstract] [Full Text] [Related]

  • 3. Lung cancer and mutations at the polymorphic NAT2 gene locus.
    Martínez C, Agúndez JA, Olivera M, Martín R, Ladero JM, Benítez J.
    Pharmacogenetics; 1995 Aug 01; 5(4):207-14. PubMed ID: 8528267
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ, Doll MA, Rustan TD, Gray K, Hein DW.
    Drug Metab Dispos; 1994 Aug 01; 22(3):371-6. PubMed ID: 7915226
    [Abstract] [Full Text] [Related]

  • 6. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism.
    Okumura K, Kita T, Chikazawa S, Komada F, Iwakawa S, Tanigawara Y.
    Clin Pharmacol Ther; 1997 May 01; 61(5):509-17. PubMed ID: 9164413
    [Abstract] [Full Text] [Related]

  • 7. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients.
    Agúndez JA, Ladero JM, Olivera M, Abildúa R, Román JM, Benítez J.
    Oncology; 1995 May 01; 52(1):7-11. PubMed ID: 7800347
    [Abstract] [Full Text] [Related]

  • 8. Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population.
    Agúndez JA, Olivera M, Martínez C, Ladero JM, Benítez J.
    Pharmacogenetics; 1996 Oct 01; 6(5):423-8. PubMed ID: 8946474
    [Abstract] [Full Text] [Related]

  • 9. Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population.
    Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Roots I.
    Pharmacogenetics; 1997 Aug 01; 7(4):327-31. PubMed ID: 9295061
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.
    Agúndez JA, Martínez C, Olivera M, Ledesma MC, Ladero JM, Benítez J.
    Clin Pharmacol Ther; 1994 Aug 01; 56(2):202-9. PubMed ID: 8062497
    [Abstract] [Full Text] [Related]

  • 11. N-acetyltransferase 2 (NAT2) polymorphism in patients with atopic asthma.
    Pawlik A, Juzyszyn Z, Gawronska-Szklarz B.
    Arch Med Res; 2009 May 01; 40(4):264-7. PubMed ID: 19608015
    [Abstract] [Full Text] [Related]

  • 12. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr 01; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 13. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
    Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I.
    Am J Hum Genet; 1995 Sep 01; 57(3):581-92. PubMed ID: 7668286
    [Abstract] [Full Text] [Related]

  • 14. Re-investigation of the concordance of human NAT2 phenotypes and genotypes.
    Bolt HM, Selinski S, Dannappel D, Blaszkewicz M, Golka K.
    Arch Toxicol; 2005 Apr 01; 79(4):196-200. PubMed ID: 15558239
    [Abstract] [Full Text] [Related]

  • 15. Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil.
    Teixeira RL, Miranda AB, Pacheco AG, Lopes MQ, Fonseca-Costa J, Rabahi MF, Melo HM, Kritski AL, Mello FC, Suffys PN, Santos AR.
    Mutat Res; 2007 Nov 01; 624(1-2):31-40. PubMed ID: 17509624
    [Abstract] [Full Text] [Related]

  • 16. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM, Amir N, Dhanasekaran S, John A, Abdulrazzaq YM, Ali BR, Bastaki S.
    Ann Hum Genet; 2017 Sep 01; 81(5):190-196. PubMed ID: 28653770
    [Abstract] [Full Text] [Related]

  • 17. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
    Skretkowicz K, Skretkowicz J, Gawrońska-Szklarz B, Górnik W, Rychlik-Sych M, Sysa-Jedrzejowska A.
    Eur J Clin Pharmacol; 2005 Jan 01; 60(11):773-8. PubMed ID: 15565348
    [Abstract] [Full Text] [Related]

  • 18. N-acetyltransferase 2 gene polymorphism and presbycusis.
    Unal M, Tamer L, Doğruer ZN, Yildirim H, Vayisoğlu Y, Camdeviren H.
    Laryngoscope; 2005 Dec 01; 115(12):2238-41. PubMed ID: 16369173
    [Abstract] [Full Text] [Related]

  • 19. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV, Bruskin SA, Abdeev RM, Markarova EV, Bigvava SG, Radkevich LA, Kozhekbaeva ZhM, Glotov AS, Gra OA, Zasedatelev AS, Nasedkina TV, Kurdanov KhA, Piruzian ES.
    Genetika; 2006 Aug 01; 42(8):1143-50. PubMed ID: 17025166
    [Abstract] [Full Text] [Related]

  • 20. Genotypes of N-acetyltransferase-2 and risk of bladder cancer: a case-control study.
    Filiadis IF, Georgiou I, Alamanos Y, Kranas V, Giannakopoulos X, Lolis D.
    J Urol; 1999 May 01; 161(5):1672-5. PubMed ID: 10210437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.